Radiotherapy comparisons
This article was originally published in The Gray Sheet
Executive Summary
A body of "poor quality" data suggests that head and neck cancer patients treated with radiation may experience a better quality of life following intensity-modulated radiotherapy compared to two-dimensional radiotherapy or three-dimensional conformal radiotherapy, the Agency for Healthcare Research and Quality said in a draft comparative effectiveness 1report released for comments July 24. That is the strongest statement possible based on what is largely insufficient evidence on the relative outcomes from four different head and neck cancer radiotherapy treatments, AHRQ says. Acknowledging that head and neck cancers are relatively rare, AHRQ urges more multicenter, randomized trials or at least observational studies with more prospective data. Comments are due Aug. 22
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.